ReviewPediatric transplantation2016
Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management.
Review in Pediatric transplantation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Solid Organ Transplantation in Inborn Errors of Metabolism: An Organ-Based, Practice-Oriented Review.Indian journal of pediatrics · 2026Review
- Living-donor liver transplantation in children with inherited metabolic and genetic cholestatic liver diseases: a single-center retrospective cohort study.Orphanet journal of rare diseases · 2026Article
- Perioperative management of pediatric patients with inborn errors of metabolism during liver transplantation.World journal of transplantation · 2026Review
- The Evolving Trend of Liver Transplantation in Metabolic Diseases: From Origins to Current Perspectives.Journal of inherited metabolic disease · 2025Review
- Pediatric liver transplant for maple syrup urine disease a single center experience.Frontiers in pediatrics · 2025Article
- Pediatric Liver Transplantation: Selection Criteria and Post-transplant Medical Management.Indian journal of pediatrics · 2024Review
- Alkaptonuria.Nature reviews. Disease primers · 2024Review
- 3D Printing of Dietary Products for the Management of Inborn Errors of Intermediary Metabolism in Pediatric Populations.Nutrients · 2023Review
- Liver transplantation for pediatric inherited metabolic liver diseases.World journal of hepatology · 2021Review
- Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs.Nutrients · 2021Review
- Outcomes After Living Donor Liver Transplantation in Pediatric Patients with Inherited Metabolic Diseases.Annals of transplantation · 2021Article
- Liver transplantation in children with inborn errors of metabolism: 30 years experience in NSW, Australia.JIMD reports · 2021Article
- Ethylmalonic encephalopathy and liver transplantation: long-term outcome of the first treated patient.Orphanet journal of rare diseases · 2021Article
- Efficacy of Living Donor Liver Transplantation in Patients with Methylmalonic Acidemia.Pediatric gastroenterology, hepatology & nutrition · 2021Article
- Nutritional Management and Biochemical Outcomes during the Immediate Phase after Liver Transplant for Methylmalonic Acidemia.Nutrients · 2020Article
- Liver transplantation in propionic and methylmalonic acidemia: A single center study with literature review.Molecular genetics and metabolism · 2019Review
- Clinical and biochemical footprints of inherited metabolic diseases. II. Metabolic liver diseases.Molecular genetics and metabolism · 2019Review
- [Inherited metabolic diseases and liver transplantation].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2019Review
- Article
- Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases.Journal of biomedical science · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
LT is an effective therapeutic option for a variety of IEM. This approach can significantly improve the quality of life of patients who suffer from severe disease manifestations and/or life-threatening metabolic decompensations despite medical/dietary management. Due to the significant risks for systemic complications from surgical stressors, careful perioperative management is vital. Even after LT, some disorders require long-term dietary restriction, medical management, and monitoring of metabolites. Successful liver transplant for these complex disorders can be achieved with disease- and patient-specific strategies using a multidisciplinary approach. In this article, we review indications, complications, perioperative management, and long-term follow-up recommendations for IEM that are treatable with LT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.